AstraZeneca's ECJ Setback May Impact European IP Protection Strategies
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Court of Justice sides with the European Commission: manipulating the patent and regulatory systems to block competitors gets AZ a slap on the wrist and serves as a warning to others.